Black History Month: 10 Pioneers to Celebrate
The generics and biosimilars industry is always pushing ahead into the future, drawing on the latest breakthroughs to advance the cause of health care access. This forward-facing stance, however, requires that we understand and appreciate the pioneers in biology, medical science and pharmacy who make our work possible. Many of those figures overcame racism and […]
AAM Announces 2022 Associate Members
WASHINGTON, DC (February 14, 2022) — The Association for Accessible Medicines (AAM) is pleased to announce its 2022 Associate Members. Associate Members are entities allied with the interests, needs and policy positions of generic and biosimilar medicine developers. Generic drugs saved the U.S. health system $338 billion in 2020, according to the Generic Drug Access & Savings in […]
Chirag Patel Named Chair of the Association for Accessible Medicines Board of Directors
WASHINGTON, DC (February 14, 2022) — The Board of Directors of the Association for Accessible Medicines (AAM) has named Chirag Patel, Amneal Pharmaceuticals Inc’s (NYSE: AMRX) Co-Founder, President and Co-Chief Executive Officer, as its new Chairman. Patel succeeds Alok Sonig, CEO, US Generics and Global Head, Generics R&D and Biosimilars of Lupin, Inc., as AAM […]
Seven Reasons to Join Us for Access! 2022
It’s a new year, and the generics and biosimilars industry is poised to achieve great things together. Join us next week, February 14-16, in Orlando, Florida, for our first in-person conference in two years, gathering leaders and experts in the name of access to prescription medicines. Register now Here are our seven reasons to attend […]
Join Us at Access! 2022 in Orlando, Florida!
Join us at the AAM annual meeting, Access! 2022, as we gather in-person for the first time in two years. This year, Access! 2022, will center around the business, breakthroughs and politics that shape our industry, as well as focus on patients in a practical and purposeful way. Join us as we get back together […]
AAM All Access Podcast: Bob Billings
AAM’s All Access Podcast lets us all learn from leaders and influential figures in health care. This series of candid, wide-ranging dialogues has given me a deeper appreciation of the dedication and brilliance of the men and women who take on the challenge of making prescription medicines more widely accessible. Only with access to prescription […]
AAM Statement on the Nomination of Dr. Robert Califf to Lead FDA
WASHINGTON, D.C. (November 12, 2021) — The Association for Accessible Medicines (AAM) welcomes the nomination of Dr. Robert Califf to lead the U.S. Food and Drug Administration (FDA). If Dr. Califf is confirmed, AAM and its member companies stand ready to work with Dr. Califf and the entire FDA team to ensure America’s patients have […]
Paula Witt Joins AAM as Senior Manager, State Government Affairs
WASHINGTON, D.C. (November 10, 2021) — Paula Witt has joined the Association for Accessible Medicines as Senior Manager, State Government Affairs. She will assist the state government affairs team in pursuing its advocacy goals and in representing the generics and biosimilars industry across the country. We’re delighted to welcome Paula to the association and to […]
Christine Simmon Named Executive Vice President, Policy and Strategic Alliances for the Association for Accessible Medicines
Veteran Association Leader Brings Wealth of Generic and Biosimilars Industry Expertise to Key Strategic Advisory Role WASHINGTON, DC (October 6, 2021) – Today, the Association for Accessible Medicines (AAM) and its Board of Directors announced the promotion of Christine Simmon to Executive Vice President, Policy and Strategic Alliances. Christine also serves as Executive Director of […]
Celebrating One Year as AAM CEO
I joined AAM just over one year ago, and one of the first things that I did was a media tour of over 25 markets around the country to talk about the incredible data contained in our 2020 annual savings report. For someone like me who spent many years working on the brand side of […]
Polly Webster Joins AAM As Vice President, Federal Affairs
WASHINGTON, D.C. (September 13, 2021) — Polly Webster is joining the Association for Accessible Medicine as Vice President, Federal Affairs. As a senior strategist and lobbyist, she will represent AAM and its member companies’ interests before Congress and the White House. She will develop short- and long-term goals in support of the federal affairs strategy […]
Scott Kuzner Joins AAM As Senior Director, Sciences and Regulatory Affairs
WASHINGTON, D.C. (September 13, 2021) — Today, Scott Kuzner, PhD, is joining the Association for Accessible Medicines as Senior Director of Sciences and Regulatory Affairs at the Association for Accessible Medicines. He will be engaged in the development and oversight of AAM’s Sciences and Regulatory Affairs initiatives. Scott comes to AAM from the United States […]
